Canadian Online Pharmacy

What's New at CBER Update

You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA).

This page has been updated recently.

Notice of Intent to Revoke (NOIR) Letter: ALK-Abello, Inc.
Posted: 3/20/2013

Notice of Intent to Revoke (NOIR) Letter: Allergy Laboratories, Inc.
Posted: 3/20/2013

Notice of Intent to Revoke (NOIR) Letter: Allermed Laboratories, Inc.
Posted: 3/20/2013

Notice of Intent to Revoke (NOIR) Letter: Antigen Laboratories, Inc.
Posted: 3/20/2013

Notice of Intent to Revoke (NOIR) Letter: Greer Laboratories, Inc.
Posted: 3/20/2013

Notice of Intent to Revoke (NOIR) Letter: Hollister-Stier Laboratories, LLC
Posted: 3/20/2013

March 15, 2013 Approval Letter - RECOTHROM
Approval Letter and Package Insert, Posted: 3/20/2013


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery